Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis. We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency, and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in FH cause hereditary leiomyomatosis and renal cell cancer (HLRCC) (7).”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [7]
In the citing paper
“Familial cancer syndromes caused by fumarate hydratase (FH) or succinate dehydrogenase (SDH) deletion suggest that these TCA enzymes can behave as classical tumor suppressors.”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Tomlinson et al., 2002
In the citing paper
“Similarly, germline mutations in the broadly expressed enzyme fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma, a familial syndrome of uterine and cutaneous leiomyomas and kidney cancer, without susceptibility to more common tumors (11).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [11]
In the citing paper
“In 2001, mutation of fumarate hydratase leading to its inactivation was discovered in renal cell cancer129. Mutation of this enzyme leads to fumarate accumulation not only in skin cancer and uterine leiomyomas but also in breast, bladder, and Leydig cell tumors130.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [130]
In the citing paper
“Consistently, heterozygous germline mutations in genes encoding the TCA cycle enzymes involved in the breakdown of these metabolites—SDH and FH—have been shown to facilitate the pathogenesis of certain rare cancers (e.g., paragangliomas) and inherited cancer-predisposition syndromes (181, 182, 183).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [183]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumo”
ResultAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · cited 1×
“Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumo”
ResultMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Inherited susceptibility to uterine leiomyomas and renal cell cancer
Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E., Sistonen, P., Herva, R., & Aaltonen, L. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051633798 · Cited by 669
Fumarase C, the stable fumarase of Escherichia coli, is controlled by the soxRS regulon.
Liochev, S. I., & Fridovich, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5892 · Cited by 239
The VHL tumour-suppressor gene paradigm
Kaelin, W. G., & Maher, E. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01558-3 · Cited by 213 · cited 1×
“, individuals with von Hippel–Lindau syndrome are predisposed to both phaeochromocytomas and renal carcinoma”
BackgroundKiuru, M., Launonen, V., Hietala, M., Aittomäki, K., Vierimaa, O., Salovaara, R., Arola, J., Pukkala, E., Sistonen, P., Herva, R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61757-9 · Cited by 209
Bourgeron, T., Chretien, D., Poggi-Bach, J., Doonan, S., Rabier, D., Letouzé, P., Munnich, A., Rötig, A., Landrieu, P., & Rustin, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117261 · Cited by 160
Alam, N. A., Bevan, S., Churchman, M., Barclay, E., Barker, K., Jaeger, E. E. M., Nelson, H. M., Healy, E., Pembroke, A. C., Friedmann, P. S., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/320124 · Cited by 160
Familial predisposition to uterine leiomyomas
Vikhliaeva, E. M., Сагдуллаевна, Х. З., & Nd, F. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)02533-i · Cited by 152 · cited 1×
“gif" NDATA ITEM> ]> Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesi”
Background
Cited by
Items 901–1,000 of 1,000
Wang, S., Ramamurthy, D., Tan, J., Liu, J., Yip, J., Chua, A., Zhang, Y., Lim, T. K., Lin, Q., Pines, O., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.09.021 · Cited by 14
Liu, X., Hong, R., Du, P., Yang, D., He, M., Wu, Q., Li, L., Wang, Y., Chen, J., Min, Q., et al. (2022) · Theranostics · doi:10.7150/thno.70814 · Cited by 21
“The mutations in the genes of isocitrate dehydrogenase (IDH1/IDH2) [8-13] and succinate dehydrogenase (SDHA/SDHB/SDHC/SDHD) [14-21] families, and fumarate hydratase (FH) [22] were found in many types of human cancers.”
BackgroundHIRA loss transforms FH -deficient cells
Valcárcel-Jiménez, L., Rogerson, C., Yong, C., Schmidt, C., Yang, M., Cremades-Rodelgo, M., Harle, V. J., Offord, V., Wong, K., Mora, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq8297 · Cited by 14
“FH loss predisposes to hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a cancer syndrome characterized by the presence of benign tumors of the skin and uterus and a highly aggressive form of renal cancer (4).”
Molecular Pathogenetics of Renal Cancer
Skolarikos, A. A., Papatsoris, A., Alivizatos, G. J., & Deliveliotis, C. (2006) · American Journal of Nephrology · doi:10.1159/000093631 · Cited by 14
Varol, A., Stapleton, K. M., & Roscioli, T. (2006) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2006.00294.x · Cited by 14
Cutaneous leiomyosarcoma arising in a smallpox scar
Pol, R. A., Dannenberg, H., Robertus, J. L., & van Ginkel, R. J. (2012) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-10-148 · Cited by 14
Heme degradation enzyme biliverdin IXβ reductase is required for stem cell glutamine metabolism
Li, Z., Nesbitt, N. M., Malone, L. E., Gnatenko, D. V., Wu, S., Wang, D., Zhu, W., Girnun, G. D., & Bahou, W. F. (2018) · Biochemical Journal · doi:10.1042/bcj20180016 · Cited by 14
“FH deficiency leads to truncation of the TCA cycle, fumarate accumulation, and hereditary leiomyomatosis and renal cell cancer [32]; the extended (glutamine to BR) heme generation/degradation pathway enables FH-deficient cells to use Li et al.”
BackgroundFumarase Deficiency: A Case With a New Pathogenic Mutation and a Review of the Literature
Peetsold, M. G., Goorden, S. M. I., Breuning, M. H., Williams, M., Bakker, J. A., Jacobs, E. H., Hussaarts-Odijk, L. M., & Peeters, C. (2020) · Journal of Child Neurology · doi:10.1177/0883073820962931 · Cited by 14
Bateman, N. W., Tarney, C. M., Abulez, T. S., Soltis, A. R., Zhou, M., Conrads, K. A., Litzi, T. A., Oliver, J., Hood, B. L., Driggers, P. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88585-x · Cited by 15
Absence of fumarate hydratase mutation in a family with cutaneous leiomyosarcoma and renal cancer
Badeloe, S., van Geest, A. J., Marion, A. M. W. V., & Frank, J. (2008) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2008.03952.x · Cited by 14
Badeloe, S., Bladergroen, R. S., Jonkman, M. F., Burrows, N., Steijlen, P. M., Poblete‐Gutiérrez, P., Steensel, M. A. M. V., van Geel, M., & Frank, J. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2008.04.005 · Cited by 14
Valencia, C. A., López, M. L. R., Barreto, A. Y. C., Rodríguez, E. G., & Díaz, C. E. A. (2016) · Familial Cancer · doi:10.1007/s10689-016-9922-4 · Cited by 14
“catalyzes the conversion of fumarate in malate during the tricarboxylic acid cycle [5, 6].”
BackgroundMetabolomics in the Diagnosis of Pheochromocytoma and Paraganglioma
Dwight, T., Kim, E., Novos, T., & Clifton-Bligh, R. J. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0926-3790 · Cited by 16
Genetic alterations and histopathologic findings in familial renal cell carcinoma.
Hansel, D. E. (2006) · PubMed · doi:10.14670/hh-21.437 · Cited by 19
A challenging frontier – the genomics and therapeutics of nonclear cell renal cell carcinoma
Patel, H. V., Srivastava, A., Srinivasan, R., & Singer, E. A. (2021) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000721 · Cited by 13
Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer
Wu, Z., Lee, Y. F., Yeo, X. H., Loo, S. Y., & Tam, W. L. (2021) · Cancers · doi:10.3390/cancers13061316 · Cited by 16
“While mutations and deletions in fumarate hydratase have been previously reported to drive a number of cancer types and are associated with a more aggressive and metastatic phenotype, its mechanistic basis in promoting disease progression was more recently clarified [73,74].”
BackgroundMitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression
Jakoubě, P., Cutano, V., González-Morena, J. M., & Keckesova, Z. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0518 · Cited by 13
FOXA2 controls the anti-oxidant response in FH-deficient cells
Rogerson, C., Sciacovelli, M., Maddalena, L. A., Pouikli, A., Segarra‐Mondejar, M., Valcárcel-Jiménez, L., Schmidt, C., Yang, M., Ivanova, E., Kent, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112751 · Cited by 15
Belle, R., Saraç, H., Salah, E., Bhushan, B., Szykowska, A., Roper, G., Tumber, A., Kriaučionis, S., Burgess-Brown, N., Schofield, C. J., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01820 · Cited by 14
Mitochondrial Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers in Cancer
Bottoni, P., Giardina, B., Pontoglio, A., Scarà, S., & Scatena, R. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_19 · Cited by 15
Genetic profiles in renal tumors
Antonio Lopez-beltran, B., Montironi, R., Egevad, L., Caballero‐Vargas, M. T., Scarpelli, M., Kırkalı, Z., & Liang Cheng, C. (2009) · International Journal of Urology · doi:10.1111/j.1442-2042.2009.02395.x · Cited by 13
Multiple Cutaneous and Uterine Leiomyomatosis or Reed Syndrome: A Retrospective Study of 13 Cases
Collgros, H., Iglesias‐Sancho, M., Tribó-Boixareu, M. J., Creus-Vila, L., Umbert-Millet, P., & Salleras‐Redonnet, M. (2015) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2014.12.013 · Cited by 13
Protein kinase inhibitors in renal cell carcinoma
Daste, A., Grellety, T., Gross‐Goupil, M., & Ravaud, A. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.869210 · Cited by 14
“This gene encodes for fumarate hydratase, a Krebs-cycle enzyme [21].”
BackgroundKamai, T., Tomosugi, N., Abe, H., Kaji, Y., Oyama, T., & Yoshida, K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131114518 · Cited by 13
“So far, FH mutations have been identified in 37 of 46 (80%) kindreds from the UK and all three Finnish kindreds examined [3,5] as well as in 31 out of 35 (89%) North American kindreds [7].”
BackgroundVanharanta, S., Wortham, N. C., Langford, C., El-Bahrawy, M. A., van der Spuy, Z. M., Sjöberg, J., Lehtonen, R., Karhu, A., Tomlinson, I. P. M., & Aaltonen, L. A. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20427 · Cited by 13
Saatchi, F., & Kirchmaier, A. L. (2019) · Genetics · doi:10.1534/genetics.119.302238 · Cited by 13
Ristau, B. T., Kamat, S. N., & Tarin, T. V. (2015) · Case Reports in Urology · doi:10.1155/2015/303872 · Cited by 14
“3–q43 and found to be the gene encoding fumarate hydratase (FH) [3].”
BackgroundTumors of the female genital organs
Micci, F., & Heim, S. (2015) · Wiley eBooks · doi:10.1002/9781118795569.ch17 · Cited by 13
Inherited Forms of Renal Cell Carcinoma
Kiuru, M. H., Kujala, M., & Aittomäki, K. (2004) · Scandinavian Journal of Surgery · doi:10.1177/145749690409300204 · Cited by 13
Dong, G., He, X., Chen, Y., Cao, H., Wang, J., Liu, X., Wang, S., Wan, S., & Xing, J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0442-x · Cited by 13
“Mutations in FH metabolic enzyme have been observed in multiple uterine leiomyomata and aggressive renal cell carcinoma [33, 34].”
BackgroundCosta, B., Dettori, D., Lorenzato, A., Bardella, C., Coltella, N., Martino, C., Cammarata, C., Carmeliet, P., Olivero, M., & Renzo, M. F. D. (2010) · The FASEB Journal · doi:10.1096/fj.09-146928 · Cited by 15
Sourbier, C., Ricketts, C. J., Liao, P., Matsumoto, S., Wei, D., Lang, M., Railkar, R. S., Yang, Y., Wei, M.-H., Agarwal, P. K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55003-2 · Cited by 14
Editorial: Kidney Cancer???A Unique Opportunity for the Development of Disease Specific Therapy
Linehan, W. M. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64156-0 · Cited by 13
Moraly, J., Kondo, T., Benzaoui, M., DuSold, J., Talluri, S., Pouzolles, M., Chien, C. D., Dardalhon, V., & Taylor, N. N. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13691 · Cited by 13
Rubinstein, W. S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.06.008 · Cited by 15
Laiho, P., Hienonen, T., Mecklin, J.-P., Järvinen, H., Karhu, A., Launonen, V., & Aaltonen, L. A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.5.e73 · Cited by 12
Photoinducible Oncometabolite Detection
Kulkarni, R. A., Briney, C. A., Crooks, D. R., Bergholtz, S. E., Mushti, C., Lockett, S., Lane, A. N., Fan, T. W. ‐., Swenson, R. E., Linehan, W. M., et al. (2018) · ChemBioChem · doi:10.1002/cbic.201800651 · Cited by 13
Noguchi, S., Ishikawa, H., Wakita, K., Matsuda, F., & Shimizu, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-70000-6 · Cited by 12
Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly
Chu, Y., Chen, C.-W. D., Lai, M., Lim, S., & Lin, W.-R. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i29.4499 · Cited by 13
Mitochondrial Factors in the Cell Nucleus
González‐Arzola, K., & Díaz-Quintana, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713656 · Cited by 12
“On the other hand, a tumour-suppressing role has also been proposed for fumarase in human cells, owing to FH mutations, which predispose individuals to common types of tumour [235].”
Backgroundde Velasco, G., Munoz, C., Sepúlveda-Sánchez, J. M., & Castellano, D. (2015) · Canadian Urological Association Journal · doi:10.5489/cuaj.2264 · Cited by 12
Renal Cell Carcinoma Deep Sequencing: Recent Developments
Farber, L. J., Furge, K., & Teh, B. T. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0230-3 · Cited by 14
Vayalil, P. K., Oh, J., Zhou, F., Diers, A. R., Smith, M. R., Golzarian, H., Oliver, P. G., Smith, R. A. J., Murphy, M. P., Velu, S. E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120460 · Cited by 15
“, pheochromocytoma, paraganglioma, familial renal cell carcinoma, glioma) [41–43].”
Management of renal cell carcinoma in young patients and patients with hereditary syndromes
Leung, C., Pan, S., & Shuch, B. M. (2016) · Current Opinion in Urology · doi:10.1097/mou.0000000000000322 · Cited by 12
“3–43, which encodes for fumarate hydratase [36,37].”
Zhou, X., Xu, M., Zeng, W., Chen, Z., Lu, G., Gong, Y., Finnell, R. H., Xiao, H., Qiao, B., & Wang, H. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0072-3 · Cited by 12
y Cajal, S. R., Hümmer, S., Peg, V., Matías‐Guiu, X., de Torres, I. M., Castellví, J., Martínez-Sáez, E. A., & Hernández‐Losa, J. (2019) · Histopathology · doi:10.1111/his.13828 · Cited by 12
Nucci, M. R., & Quade, B. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0764-9.00020-2 · Cited by 12
Hauttumoren als Markerläsionen hereditärer Tumorsyndrome
Mentzel, T., Kutzner, H., Requena, L., & Hartmann, A. (2010) · Der Pathologe · doi:10.1007/s00292-010-1361-7 · Cited by 12
No germline FH mutations in familial breast cancer patients
Kiuru, M. H., Lehtonen, R., Eerola, H., Aittomäki, K., BLOMQVIST, C. P., Nevanlinna, H. A., Aaltonen, L. A., & Launonen, V. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201326 · Cited by 12
Epidemiology of Renal Cell Carcinoma
Patel, P. H., & Srinivas, S. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_1 · Cited by 14
Anaplerotic reactions in tumour proliferation and apoptosis
Quash, G., Fournet, G., & Reichert, U. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00106-0 · Cited by 12
Degenhardt, J., Tolkach, Y., Amin, M. B., Mosiello, G., Baydar, D. E., Gall, É. C.-L., DiCola, J., Elhag, D., Frezza, C., Halbritter, J., et al. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf032 · Cited by 11
Advanced treatments in non-clear renal cell carcinoma.
Tazi, E. M., Essâdi, I., Tazi, M. F., Ahellal, Y., Mâ€TMRabti, H., & Errihani, H. H. (2011) · Urology journal./Urology jornal. · Cited by 11
RetractedAl‐Obaidy, K. I., Alruwaii, Z. I., Williamson, S. R., & Cheng, L. (2022) · Histopathology · doi:10.1111/his.14641 · Cited by 12
“It is a tumour suppressor gene that requires a ‘two-hit/bi-allelic’ inactivating mutation for tumour development, ‘one-hit’ being germline.(40) It encodes fumarate hydratase enzyme, a critical enzyme involved in converting fumarate to malate in the tricarboxylic acid (TCA) cycle in the mitochondria.”
BackgroundKim, G., Jang, G., Song, J., Kim, D., Lee, S., Joo, J. W. J., & Jang, W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274879 · Cited by 12
“Germline mutations in fumarate hydratase, a tumor suppressor gene, stimulate benign and malignant tumor development of UF [8, 9].”
BackgroundSolaimuthu, B., Lichtenstein, M., Hayashi, A., Khatib, A., Plaschkes, I., Nevo, Y., Tanna, M., Pines, O., Shaul, Y. D., & Shaul, Y. D. (2022) · Cancers · doi:10.3390/cancers14225508 · Cited by 13
Mutations of FH and IDH may induce gliomagenesis by similar mechanisms
Raghunathan, A., Ida, C. M., Westbroek, E. M., Gupta, S., Jenkins, R. B., Giannini, C., & Aldape, K. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac107 · Cited by 11
Zhu, L., Hong, Y., Zhu, Z.-R., Huang, J., Wang, J., Li, G., Wu, X., Chen, Y., Xu, Y., Zheng, L., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06510-2 · Cited by 12
Single Base Mutation in the Fumarate Hydratase Gene Leading to Segmental Cutaneous Leiomyomatosis
Huter, E., Wortham, N. C., Hartschuh, W., Enk, A., & Jappe, U. (2008) · Acta Dermato Venereologica · doi:10.2340/00015555-0341 · Cited by 11
Howitt, B. E., Nucci, M. R., & Quade, B. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-44732-4.00020-0 · Cited by 11
Gregorio, E. D., Miolo, G., Saorin, A., Steffan, A., & Corona, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115574 · Cited by 12
“The breakthrough for the Warburg revival coincided with the finding of specific mutated genes encoding for enzymes of the tricarboxylic acid (TCA) cycle as the succinate dehydrogenase (SDH) [25,26] and fumarate hydratase (FH) [27].”
BackgroundMori, S., Gotoh, O., Kiyotani, K., & Low, S. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00940-y · Cited by 11
The Crucial Roles of Intermediate Metabolites in Cancer
Huang, S., Wang, Z., & Zhao, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s321433 · Cited by 11
“Fumarate Abnormal fumarate accumulation is attributed to inactivating mutations in FH, which have been reported in skin leiomyomata, uterine fibroids, and papillary renal cell cancer.(82) Fumarate appears to be multifaceted.”
BackgroundRivera‐Cruz, G., Boyraz, B., & Petrozza, J. C. (2021) · F&S Reports · doi:10.1016/j.xfre.2021.10.002 · Cited by 11
“In addition to somatic changes, germline pathogenic variants in FH have been associated with an increased risk of early-onset uterine leiomyomas (5, 6).”
BackgroundDai, Y., Liu, X., Zhu, Y., Mao, S., Yang, J., & Lan, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.890007 · Cited by 11
“Familial clustering between first-degree relatives and twins was also observed as well as multiple inherited syndromes in which fibroid development occurred[10, 11].”
BackgroundWarburg effect and renal cancer caused by errs in fumarate hydratase encoding gene
Qureshi, A. S., & Ali, S. (2019) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/32/2/01.03.2019/4965/743-749 · Cited by 12
Starker, L. F., Delgado-Verdugo, A., Udelsman, R., Björklund, P., & Carling, T. (2010) · Endocrine · doi:10.1007/s12020-010-9399-0 · Cited by 11
“The role of TCA enzymes as tumor suppressors has broadened since the identification of the SDHD gene in 2000 [14], with mutations of fumarate hydratase reported as the cause of hereditary renal-cell cancer and leiomyomatosis [ 16 ], and the identification of somatic genetic aberrations of isocitrate dehydrogenase gene…”
BackgroundCurrent understanding of the molecular mechanisms of kidney cancer: a primer for urologists
Lim, D., Ko, R., & Pautler, S. E. (2012) · Canadian Urological Association Journal · doi:10.5489/cuaj.63 · Cited by 11
Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism
Tevosian, S. G., & Ghayee, H. K. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01991 · Cited by 12
Fan, Z., Li, L., Li, X., Zhang, M., Dou, M., Zhao, J., Cao, J., Deng, X., Zhang, M., Li, H., et al. (2019) · Aging · doi:10.18632/aging.101761 · Cited by 11
Peng, L., Mao, Q., Jiang, B., Zhang, J., Zhao, Y.-L., Teng, X., Yang, J., Xia, Y., Chen, S., Stebbing, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.549168 · Cited by 11
Rathmell, W. K., & Godley, P. A. (2004) · Current Opinion in Oncology · doi:10.1097/00001622-200405000-00010 · Cited by 12
No fumarate hydratase (FH) mutations in hereditary prostate cancer
Lehtonen, R., Kiuru, M. H., Rökman, A., Ikonen, T., Cunningham, J. M., Schaid, D. J., Matikainen, M., Nupponen, N. N., Karhu, A., Kallioniemi, O.-P., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.3.e19 · Cited by 12
Clinical and molecular risk factors for repeat interventions due to symptomatic uterine leiomyomas
Khamaiseh, S., Äyräväinen, A., Arffman, M., Reinikka, S., Mehine, M. M., Härkki, P., Bützow, R. C., Pasanen, A. M., & Vahteristo, P. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.06.051 · Cited by 10
Álvarez-González, E., & Sierra, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169054 · Cited by 10
“The accumulation of fumarate [7,84] due to loss-of-function mutations at the FH encoding gene [84,146,147] causes the development of hereditary leiomyomatosis and renal cell cancer (HLRCC) [84,146,148–152].”
BackgroundCardiometabolic disease and cardio-oncology: Insights from iPSC models and tissue engineering
Kojic, A., Moslehi, J. J., Ky, B., & Wu, J. C. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102261 · Cited by 14
Update on Genetic Conditions Affecting the Skin and the Kidneys
Reimer‐Taschenbrecker, A., He, Y., & Has, C. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00043 · Cited by 10
“Genetics and Molecular Pathology Hereditary leiomyomatosis and renal cell cancer is caused by monoallelic FH mutations that lead to reduced activity of the enzyme fumarate hydratase (109).”
BackgroundEndocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids
Elkafas, H., Badary, O. A., Morsy, E. M. E., Kamel, R., Yang, Q., & Al-Hendy, A. A. (2021) · Journal of Advanced Pharmacy Research · doi:10.21608/aprh.2021.66748.1124 · Cited by 13
The epigenetic–metabolic interplay in gliomagenesis
Phasaludeen, B., Emerald, B. S., & Ansari, S. A. (2022) · Open Biology · doi:10.1098/rsob.210350 · Cited by 10
Schouten, L. J., van de Pol, J. A. A., Kviatkovsky, M. J., & van den Brandt, P. A. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102171 · Cited by 11
Gurruchaga, I., Alves, A. N., Arregui, S. V., & Lobera, C. S. (2021) · Current Oncology · doi:10.3390/curroncol28040216 · Cited by 10
Yip, J., Wang, S., Tan, J., Lim, T. K., Lin, Q., Zhang, Y., Karmon, O., Pines, O., & Lehming, N. (2021) · iScience · doi:10.1016/j.isci.2021.103354 · Cited by 10
“…of cancer (Hanahan and Weinberg, 2011), and a study with patients suffering from hereditary leiomyomatosis and renal cell cancer (HLRCC) identified fumarase as a tumor suppressor (Tomlinson et al., 2002), suggesting that HLRCC could be caused by the DNA repair defect of cells lacking fumarase.”
BackgroundDiseases of Hereditary Renal Cell Cancers
Iliopoulos, O. (2023) · Urologic Clinics of North America · doi:10.1016/j.ucl.2023.01.010 · Cited by 11
Makino, T., Nagasaki, A., Furuichi, M., Matsui, K., Watanabe, H., Sawamura, D., Shimizu, H., & Shimizu, T. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.07.009 · Cited by 10
Marque, M., Gardie, B., Paillerets, B. B., Rustin, P., Guillot, B., Richard, S., & Bessis, D. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09912.x · Cited by 10
Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer
Bevan, S., Edwards, S. M., Jones, A.-B., Dowe, A., Southgate, C., The CRC/BPG UK Familial Prostate Cancer Study Collaborators, Dearnaley, D. P., Easton, D. F., Houlston, R. S., & Eeles, R. A. (2003) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500616 · Cited by 10
Kuroda, N., Ohe, C., Kato, I., Furuya, M., Baba, M., Nagashima, Y., Nakatani, Y., Murakami, I., Zhou, M., Michal, M., et al. (2018) · Polish Journal of Pathology · doi:10.5114/pjp.2017.73920 · Cited by 10
“The loss of chromosome 1q was observed as expected findings compatible with tumor suppressor role of FH gene [5, 8, 15, 22, 42, 75].”
BackgroundInfluentialWalsh, M. F., Cadoo, K. A., Salo‐Mullen, E. E., Dubard-Gault, M. E., Stadler, Z. K., & Offit, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00013-x · Cited by 11
Aryl Hydrocarbon Receptor-Interacting Protein and Acromegaly
Aaltonen, L. A. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110607 · Cited by 10
Trpkov, K., & Siadat, F. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.143 · Cited by 10
“Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): Renal cancer risk, surveillance and treatment.”
BackgroundInfluentialGoad, J., & Rajkovic, A. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.08.037 · Cited by 9
The evolving roles of pathologists in paragangliomas and pheochromocytomas
Mete, Ö., & Juhlin, C. C. (2025) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-025-04379-w · Cited by 10
“FH -mutated PPGLs are rare but clinically important, as they signify hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome [35, 36].”
Scharnitz, T., Nakamura, M., Koeppe, E. S., Henry, M.-L., Lowe, L., Else, T., & Cha, K. B. (2023) · PubMed Central · Cited by 16
Mitochondrial Protein in the Nucleus
Tang, B. L. (2015) · CellBio · doi:10.4236/cellbio.2015.42003 · Cited by 11
“They also provided a potential explanation for the human fumarate hydratase (FH) gene being a susceptibility locus for a known genetic predisposition to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) [27].”
BackgroundAnetoderma arising in Reed syndrome: a case report and review of the literature
Velez, M. J., Mesinkovska, N. A., & Bergfeld, W. F. (2015) · Journal of Cutaneous Pathology · doi:10.1111/cup.12524 · Cited by 9
Vaidya, S., Shaik, N. A., Latha, M., Chava, S. P., Mohiuddin, M. K., Yalla, A., Rao, K. P., Kodati, V. L., & Hasan, Q. A. (2012) · Tumor Biology · doi:10.1007/s13277-012-0391-6 · Cited by 9
“Mutations in FH result in reduced enzyme activity that leads to two distinct phenotypes in affected individuals; for example, homozygous (or compound heterozygous) FH germ line mutations are described to cause autosomal recessive childhood encephalopathy called FH deficiency [14–16], whereas germ line heterozygous mut…”
BackgroundInsights into the role of NRF2 in cancer provided by cancer genomics
Pölönen, P., & Levonen, A. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.09.002 · Cited by 9
The genomics of renal cell carcinoma and its role in renal mass biopsy
Salami, S. S., George, A. K., & Udager, A. M. (2018) · Current Opinion in Urology · doi:10.1097/mou.0000000000000516 · Cited by 9
Høgh, R. I., Droujinine, A., Møller, S. H., Jepsen, S. D., Mellergaard, M., Andresen, L. O., & Skov, S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900740 · Cited by 10
Kidney cancer: from genes to therapy
Webster, B. R., Rompré‐Brodeur, A., Daneshvar, M., Pahwa, R., & Srinivasan, R. (2021) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2021.100773 · Cited by 10
Metadata
- Authors
- The Multiple Leiomyoma Consortium
- Venue
- Nature Genetics
- Published
- 2002-02-25
- Volume
- 30
- Issue
- 4
- Pages
- 406-410
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1967291345
- Cited by
- 1,635
- References
- 17
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 64 · 2023: 57 · 2022: 65 · 2021: 80 · 2020: 93 · 2019: 86 · 2018: 81 · 2017: 90 · 2016: 106 · 2015: 89 · 2014: 85 · 2013: 82 · 2012: 82
- FWCI
- 56.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- U.S. Public Health Service (U59309)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- fumarate hydratase, FH gene, germline mutations, uterine fibroids, cutaneous leiomyoma, papillary renal cell carcinoma, cancer susceptibility, tumor suppressor, fumarate hydratase deficiency, compound heterozygosity, TCA cycle, fibroid pathogenesis
- MeSH terms
- Alleles, Carcinoma, Papillary, Carcinoma, Renal Cell, Chromosomes, Human, Pair 1, Exons, Female, Fumarate Hydratase, Genes, Dominant, Genetic Markers, Humans, Kidney Neoplasms, Leiomyoma, Male, Mutation, Pedigree, Recombination, Genetic, Uterine Neoplasms, Gene Deletion, In Situ Hybridization, Fluorescence, Sequence Analysis, DNA, Germ-Line Mutation, Leiomyoma, Epithelioid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.